BEL1 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Significance

BEL1 is a viral transactivator protein essential for the replication and transcription of foamy viruses . Unlike other retroviral proteins, BEL1 is unique to foamy viruses and modulates host-cell interactions to facilitate viral propagation . The BEL1 antibody enables the detection and functional study of this protein in laboratory settings, serving as a cornerstone for virology research.

Functional Domains of BEL1 Protein

Studies on HFV BEL1 reveal a complex domain architecture critical for its activity :

DomainFunctionKey Features
N-terminal (1–76)Nuclear localization signal (NLS)Basic amino acid-rich motif enabling nuclear entry
Central (82–150)Positive regulatory domainOvercomes inhibitory effects of flanking regions; essential for transactivation
C-terminal (153–225)Activation domainDrives transcriptional activation in yeast and mammalian systems
Effector RegionInteraction with cellular proteinsMutations here disrupt transactivation or create dominant-negative variants

Functional mutagenesis studies identified residues critical for DNA binding and transcriptional activation, with missense mutations in the effector region abolishing activity .

Mechanistic Insights

  • BEL1 binds host-cell proteins to hijack transcriptional machinery, enabling viral gene expression .

  • The C-terminal activation domain functions independently of sequence homology to canonical acidic activation domains, suggesting a unique evolutionary adaptation .

  • Regulatory domains (N- and C-terminal) suppress activation unless counterbalanced by the central positive domain .

Experimental Applications

  • Diagnostics: Used in ELISA and WB to detect FFV infections in feline populations .

  • Pathogenesis Studies: Elucidates how BEL1 modulates host-cell environments to promote viral persistence .

Comparative Analysis of Foamy Virus BEL1

VirusBEL1 HomologKey Functional SimilaritiesUnique Features
Feline Foamy Virus (FFV)Bel-1Nuclear localization, transcriptional activationSpecies-specific immunogenic epitopes
Human Foamy Virus (HFV)Bel1Bipartite NLS, effector domain for host interactionsBroader host-cell tropism in human-derived models

Ongoing Challenges and Future Directions

  • Antibody Validation: Cross-reactivity with non-target proteins remains a concern, necessitating rigorous validation using knockout models .

  • Therapeutic Potential: While BEL1 is not yet a direct therapeutic target, understanding its role could inform antiviral strategies against foamy viruses.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
BEL1 antibody; BELL1 antibody; At5g41410 antibody; MYC6.12Homeobox protein BEL1 homolog antibody
Target Names
BEL1
Uniprot No.

Target Background

Function
BEL1 plays a critical role in ovule development, influencing ovule patterning and determining integument identity through its interactions with MADS-box factors. The formation of a complex with AG-SEP dimers inhibits the carpel identity process, promoting the maintenance of ovule identity. The BEL1-STM complex maintains the indeterminate nature of the inflorescence meristem. BEL1, in conjunction with SPL, is required for cytokinin-induced PIN1 expression in ovules.
Gene References Into Functions
  1. BEL1 interacts with the ovule identity MADS box factors when they dimerize with SEPALLATA proteins. PMID: 17693535
Database Links

KEGG: ath:AT5G41410

STRING: 3702.AT5G41410.1

UniGene: At.24568

Protein Families
TALE/BELL homeobox family
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in both floral and vegetative tissues.

Q&A

Here’s a structured FAQ collection for researchers working with BEL1 Antibody, synthesized from peer-reviewed methodologies and technical guidelines:

Advanced Research Questions

How to resolve discrepancies in BEL1 subcellular localization across studies?

  • Analysis framework:

    • Technical variables: Compare fixation methods (e.g., paraformaldehyde vs. methanol) .

    • Biological variables: Assess cell cycle stage (BEL1 may shuttle nucleus↔cytoplasm) .

    • Data harmonization: Use meta-analysis tools (e.g., RevMan) to quantify heterogeneity across ≥5 studies .

What strategies mitigate BEL1 Antibody cross-reactivity in multi-target assays?

  • Apply:

    • Sequential staining: Use BEL1 first with high-affinity fluorophores (e.g., PE), followed by lower-affinity markers .

    • Computational compensation: Employ spectral unmixing algorithms (e.g., Cytek SpectroFlo®) .

    • Epitope mapping: Map BEL1-binding region via HDX-MS to identify overlapping motifs with off-targets .

How to design mechanistic studies linking BEL1 to downstream signaling?

  • Integrated workflow:

    • Proximity ligation assays: Identify BEL1 interaction partners (e.g., NF-κB) .

    • Phospho-specific flow cytometry: Couple BEL1 staining with p-AKT/p-ERK detection .

    • Conditional knockout models: Use tamoxifen-inducible Cre systems to assess temporal effects .

Technical Troubleshooting

Why does BEL1 Antibody yield variable results between batches?

  • Root causes:

    CauseSolution
    Glycosylation variabilityUse PNGase F-treated lysates for Western blot normalization
    AggregationPre-clear antibody with 100 kDa centrifugal filters
    Epitope degradationValidate antigen integrity via MALDI-TOF post-extraction

How to adapt BEL1 assays for low-abundance targets in primary cells?

  • Implement:

    • Signal amplification: Tyramide-based systems (e.g., TSA Plus) .

    • Pre-enrichment: Magnetic bead sorting with anti-BEL1 conjugated microspheres .

    • Single-cell RNA-seq correlation: Validate protein-mRNA concordance in 10x Genomics data .

Data Interpretation Guidelines

How to contextualize conflicting BEL1 expression data in public databases?

  • Use consensus scoring:

    • Harmonize data from ≥3 sources (e.g., HPA, GTEx, GEO) via ComBat batch correction .

    • Apply clinical correlation: Stratify results by patient subcohorts (e.g., ER+ vs. TNBC in breast cancer) .

What statistical methods adjust for BEL1 heterogeneity in tumor samples?

  • Apply:

    • Spatial analysis: QuPath for regional expression quantification .

    • Mixed-effects models: Account for intra-tumor variability using lme4 in R .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.